Abstract
Dementia is the chronic and progressive loss of memory and at least one other cognitive function. In many cases, the history must be provided by a family member or friend because the patient has little insight into their problem. Mental status examination should focus on tests of attention, memory, language, praxis, construction, mental flexibility, and processing speed. The combination of the history and mental status examination allows diagnosis in most cases. Structural and functional neuroimaging studies usually play confirmatory roles. Common causes of dementia include Alzheimer disease, dementia with Lewy bodies, frontotemporal dementia, vascular dementia, and normal pressure hydrocephalus. Mild cognitive impairment and subjective memory impairment refer to transitional states from normal to abnormal which precede full-blown dementia. Important mimics of dementia include depression, obstructive sleep apnea, pain, and attention deficit-hyperactivity disorder. Rapidly progressive dementias often come to attention in the inpatient setting, and the most important causes are Creutzfeldt–Jakob disease, Hashimoto encephalopathy, and cancer-associated processes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
Barthel H, Gertz HJ, Dresel S, et al. Cerebral amyloid-beta PET with florbetaben (18F) in patients with Alzheimer’s disease and healthy controls: a multicentre phase 2 diagnostic study. Lancet Neurol. 2011;10:424–35.
Beck AT, Ward CH, Mendelson M, Mock JE, Erbaugh JK. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–71.
Bedard M-A, Montplaisir J, Richer F, Rouleau I, Malo J. Obstructive sleep apnea syndrome: pathogenesis of neuropsychological deficits. J Clin Exp Neuropsychol. 1991;13:950–64.
Bhasin JM, Rowan E, Edwards K, McKeith I. Cholinesterase inhibitors in dementia with Lewy bodies: a comparative analysis. Int J Geriatr Psychiatry. 2007;22:890–5.
Castillo P, Woodruff B, Caselli R, et al. Steroid-responsive encephalopathy associated with autoimmune thyroiditis. Arch Neurol. 2006;63:197–202.
Chong JY, Rowland LP, Utiger RD. Hashimoto encephalopathy. Syndrome or myth? Arch Neurol. 2003;60:164–71.
Clark CM, Schneider JA, Bedell BJ, et al. Use of florbetapir-PET for imaging beta-amyloid pathology. JAMA. 2011;305:275–83.
Crutch SJ, Lehmann M, Schott JM, et al. Posterior cortical atrophy. Lancet Neurol. 2012;11:170–8.
Dikmen S, Machamer J, Fann JR, Temkin NR. Rates of symptom reporting following traumatic brain injury. J Int Neuropsychol Soc. 2010;16:401–11.
Ferman TJ, Smith GE, Boeve BF, et al. DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging. Neurology. 2004;62:181–7.
Gilman S, Koeppe RA, Little R, et al. Differentiation of Alzheimer’s disease from dementia with Lewy bodies utilizing positron emission tomography with 18-fluorodeoxyglucose and neuropsychological testing. Exp Neurol. 2005;191:S95–103.
Gorno-Tempini ML, Dronkers NF, Rankin KP, et al. Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol. 2004;55:335–46.
Hebb AO, Cusimano MD. Idiopathic normal pressure hydrocephalus: a systemic review of diagnosis and outcome. Neurosurgery. 2001;49:1166–86.
Hellmuth J, Mirsky J, Heuer HW, et al. Multicenter validation of a bedside antisaccade task as a measure of executive function. Neurology. 2012;78:1824–31.
Ibach B, Poljansky S, Marienhagen J, et al. Contrasting metabolic impairment in frontotemporal degeneration and early onset alzheimer’s disease. Neuroimage. 2004;23:739–43.
Jessen F, Wiese B, Bachmann C, et al. Prediction of dementia by subjective memory impairment. Arch Gen Psychiatry. 2010;67:414–22.
Johnson KA, Jones K, Holman BL, et al. Preclinical prediction of Alzheimer’s disease using SPECT. Neurology. 1998;50:1563–71.
Koepsell TD, Monsell SE. Reversion from mild cognitive impairment to normal or near-normal cognition. Neurology. 2012;79:1591–8.
Levy JA, Chelune GJ. Cognitive-behavioral profiles of neurodegenerative dementias: beyond Alzheimer’s disease. J Geriatr Psychiatry Neurol. 2007;20:227–38.
Leys D, Pasquier F. Poststroke dementia. In: Bogousslavsky J, Caplan L, editors. Stroke syndromes. Cambridge: Cambridge University Press; 2001. p. 273–84.
Likeman M, Anderson VM, Stevens JM, et al. Visual assessment of atrophy on magnetic resonance imaging in the diagnosis of pathologically confirmed young-onset dementias. Arch Neurol. 2005;62:1410–5.
Malouf R, Birks J. Donepezil for vascular cognitive impairment. Cochrane Database Syst Rev. 2004;1:CD004395.
McAllister TW, Arciniegas D. Evaluation and treatment of postconcussive symptoms. NeuroRehabilitation. 2002;17:265–83.
McArthur JC. HIV dementia: an evolving disease. J Neuroimmunol. 2004;157:3–10.
McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology. 2005;65:1863–72.
Mesulam MM. Primary progressive aphasia: a 25-year retrospective. Alzheimer Dis Assoc Disord. 2007;21:S8–11.
Minoshima S, Foster NL, Sima AAF, et al. Alzheimer’s disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Ann Neurol. 2001;50:358–65.
Ochipa C, Gonzalez Rothi LJ. Limb apraxia. Semin Neurol. 2000;20:471–8.
Petersen RC. Mild cognitive impairment: current research and clinical implications. Semin Neurol. 2007;27:22–31.
Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303–8.
Rowe CC, Ellis KA, Rimajova M, et al. Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiol Aging. 2010;31:1275–83.
Shiga Y, Miyazawa K, Sato S, Fukushima R. Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Neurology. 2004;63:443–9.
Shively S, Scher AI, Perl DP, Diaz-Arrastia R. Dementia resulting from traumatic brain injury. What is the pathology? Arch Neurol. 2012;69:1245–51.
Sonnen JA, Montine KS, Quinn JF, et al. Biomarkers for cognitive impairment and dementia in elderly people. Lancet Neurol. 2008;7:704–14.
Tombaugh TN, McIntyre NJ. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc. 1992;40:922–35.
Tombaugh TN, Kozak J, Rees L. Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming. Arch Clin Neuropsychol. 1999;14:167–77.
Tournier-Lasserve E, Joutel A, Melki J, et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nat Genet. 1993;3:256–9.
Vandenberghe R, Van Laere K, Ivanoiu A, et al. 18-F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial. Ann Neurol. 2010;68:319–29.
Vossel KA, Miller BL. New approaches to the treatment of frontotemporal lobar degeneration. Curr Opin Neurol. 2008;21:708–16.
Wahlund L-O, Julin P, Johansson S-E, Scheltens P. Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study. J Neurol Neurosurg Psychiatry. 2000;69:630–5.
Warren JD, Schott JM, Fox NC, et al. Brain biopsy in dementia. Brain. 2005;128:2016–25.
Wikkelso C, Andersson H, Blomstrand C, Lindqvist G. The clinical effect of lumbar puncture in normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry. 1982;45:64–9.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Tarulli, A. (2016). Dementia. In: Neurology. Springer, Cham. https://doi.org/10.1007/978-3-319-29632-6_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-29632-6_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-29630-2
Online ISBN: 978-3-319-29632-6
eBook Packages: MedicineMedicine (R0)